NCT06444308 Community Health Worker-led Hypertension Management
| NCT ID | NCT06444308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 460 participants |
| Start Date | 2024-09-09 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 460 participants in total. It began in 2024-09-09 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to determine if hypertension management by community health workers (CHW) supported by a mobile health application and remote physician supervision is non-inferior to management by a physician for the primary outcome of improvement in systolic blood pressure. The target population is patients with hypertension in rural Guatemala. Study duration will be 12-24 months.
Eligibility Criteria
Inclusion Criteria: * Adults age 18 or greater with diagnosis of hypertension AND blood pressure (BP) greater than or equal to 140/90 OR currently taking antihypertensive medication. * Ability to provide informed consent Exclusion Criteria: * Pregnancy * Severe comorbid condition(s) with life expectancy less than 1 year
Contact & Investigator
Sean Duffy, MD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06444308 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06444308 currently recruiting?
Yes, NCT06444308 is actively recruiting participants. Contact the research team at sean.duffy@fammed.wisc.edu for enrollment information.
Where is the NCT06444308 trial being conducted?
This trial is being conducted at San Lucas Tolimán, Guatemala.
Who is sponsoring the NCT06444308 clinical trial?
NCT06444308 is sponsored by University of Wisconsin, Madison. The principal investigator is Sean Duffy, MD at University of Wisconsin, Madison. The trial plans to enroll 460 participants.